C/EBPβ is AMP kinase sensitive and up-regulates PEPCK in response to ER stress in hepatoma cells

Molecular and Cellular Endocrinology

Volumn 331, Issue 1, 2011, Pages 102-108

  Choudhury, Mahua ^a   Qadri, Ishtiaq ^a,c   Rahman, Shaikh Mizanoor ^a   Schroeder Gloeckler, Jill ^a,d   Janssen, Rachel C ^a   Friedman, Jacob E ^a,b  

^a Nutrition Obesity Research Center at the University of Colorado   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NATIONAL UNIVERSITY OF SCIENCES AND TECHNOLOGY   (Pakistan)

^d Owens Community College   (United States)

Author keywords

C EBP ; ER stress; Gluconeogenesis; PAMPK; XBP1 spliced

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; ENZYME REGULATION; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; TRANSCRIPTION INITIATION; UPREGULATION;

ADENYLATE KINASE; ANIMALS; CARCINOMA, HEPATOCELLULAR; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MODELS, GENETIC; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); PROTEIN BINDING; PROTEIN KINASE INHIBITORS; RATS; RESPONSE ELEMENTS; STRESS, PHYSIOLOGICAL; THAPSIGARGIN; UP-REGULATION;

EID: 78149411370     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.08.014     Document Type: Article

References (47)

1. Arai N., Masuzaki H., Tanaka T., Ishii T., Yasue S., Kobayashi N., Tomita T., Noguchi M., Kusakabe T., Fujikura J., Ebihara K., Hirata M., Hosoda K., Hayashi T., Sawai H., Minokoshi Y., Nakao K. Ceramide and adenosine 5′-monophosphate-activated protein kinase are two novel regulators of 11beta-hydroxysteroid dehydrogenase type 1 expression and activity in cultured preadipocytes. Endocrinology 2007, 148:5268-5277.
2. Arizmendi C., Liu S., Croniger C., Poli V., Friedman J.E. The transcription factor CCAAT/enhancer-binding protein beta regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes. J. Biol. Chem. 1999, 274:13033-13040.
3. Baan B., van Dam H., van der Zon G.C., Maassen J.A., Ouwens D.M. The role of c-Jun N-terminal kinase, p38, and extracellular signal-regulated kinase in insulin-induced Thr69 and Thr71 phosphorylation of activating transcription factor 2. Mol. Endocrinol. 2006, 20:1786-1795.
4. Back S.H., Schroder M., Lee K., Zhang K., Kaufman R.J. ER stress signaling by regulated splicing: IRE1/HAC1/XBP1. Methods 2005, 35:395-416.
5. Barthel A., Schmoll D., Kruger K.D., Roth R.A., Joost H.G. Regulation of the forkhead transcription factor FKHR (FOXO1a) by glucose starvation and AICAR, an activator of AMP-activated protein kinase. Endocrinology 2002, 143:3183-3186.
6. Borradaile N.M., Han X., Harp J.D., Gale S.E., Ory D.S., Schaffer J.E. Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J. Lipid Res. 2006, 47:2726-2737.
7. Chen A., Mumick S., Zhang C., Lamb J., Dai H., Weingarth D., Mudgett J., Chen H., MacNeil D.J., Reitman M.L., Qian S. Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. Obes. Res. 2005, 13:1311-1320.
8. Chen K.D., Chen L.Y., Huang H.L., Lieu C.H., Chang Y.N., Chang M.D., Lai Y.K. Involvement of p38 mitogen-activated protein kinase signaling pathway in the rapid induction of the 78-kDa glucose-regulated protein in 9L rat brain tumor cells. J. Biol. Chem. 1998, 273:749-755.
9. Choudhury M., Shukla S.D. Surrogate alcohols and their metabolites modify histone H3 acetylation: involvement of histone acetyl transferase and histone deacetylase. Alcohol Clin. Exp. Res. 2008, 32:829-839.
10. Guo W., Wong S., Xie W., Lei T., Luo Z. Palmitate modulates intracellular signaling, induces endoplasmic reticulum stress, and causes apoptosis in mouse 3T3-L1 and rat primary preadipocytes. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E576-E586.
11. Harding H.P., Calfon M., Urano F., Novoa I., Ron D. Transcriptional and translational control in the mammalian unfolded protein response. Annu. Rev. Cell Dev. Biol. 2002, 18:575-599.
12. Harding H.P., Zhang Y., Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 1999, 397:271-274.
13. Herzig S., Long F., Jhala U.S., Hedrick S., Quinn R., Bauer A., Rudolph D., Schutz G., Yoon C., Puigserver P., Spiegelman B., Montminy M. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001, 413:179-183.
14. Horike N., Sakoda H., Kushiyama A., Ono H., Fujishiro M., Kamata H., Nishiyama K., Uchijima Y., Kurihara Y., Kurihara H., Asano T. AMP-activated protein kinase activation increases phosphorylation of glycogen synthase kinase 3beta and thereby reduces cAMP-responsive element transcriptional activity and phosphoenolpyruvate carboxykinase C gene expression in the liver. J. Biol. Chem. 2008, 283:33902-33910.
15. Hossain P., Kawar B., El Nahas M. Obesity and diabetes in the developing world - a growing challenge. N. Engl. J. Med. 2007, 356:213-215.
16. Koo S.H., Flechner L., Qi L., Zhang X., Screaton R.A., Jeffries S., Hedrick S., Xu W., Boussouar F., Brindle P., Takemori H., Montminy M. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 2005, 437:1109-1111.
17. Le Lay J., Tuteja G., White P., Dhir R., Ahima R., Kaestner K.H. CRTC2 (TORC2) contributes to the transcriptional response to fasting in the liver but is not required for the maintenance of glucose homeostasis. Cell Metab. 2009, 10:55-62.
18. Leclerc I., Lenzner C., Gourdon L., Vaulont S., Kahn A., Viollet B. Hepatocyte nuclear factor-4alpha involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase. Diabetes 2001, 50:1515-1521.
19. Lee A.H., Scapa E.F., Cohen D.E., Glimcher L.H. Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 2008, 320:1492-1496.
20. Li Y., Bevilacqua E., Chiribau C.B., Majumder M., Wang C., Croniger C.M., Snider M.D., Johnson P.F., Hatzoglou M. Differential control of the CCAAT/enhancer-binding protein beta (C/EBPbeta) products liver-enriched transcriptional activating protein (LAP) and liver-enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the response to endoplasmic reticulum stress. J. Biol. Chem. 2008, 283:22443-22456.
21. Liu J.S., Park E.A., Gurney A.L., Roesler W.J., Hanson R.W. Cyclic AMP induction of phosphoenolpyruvate carboxykinase (GTP) gene transcription is mediated by multiple promoter elements. J. Biol. Chem. 1991, 266:19095-19102.
22. Liu S., Croniger C., Arizmendi C., Harada-Shiba M., Ren J., Poli V., Hanson R.W., Friedman J.E. Hypoglycemia and impaired hepatic glucose production in mice with a deletion of the C/EBPbeta gene. J. Clin. Invest. 1999, 103:207-213.
23. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., Mu J., Foufelle F., Ferre P., Birnbaum M.J., Stuck B.J., Kahn B.B. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004, 428:569-574.
24. Mori K. Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 2000, 101:451-454.
25. Nakatani Y., Kaneto H., Kawamori D., Yoshiuchi K., Hatazaki M., Matsuoka T.A., Ozawa K., Ogawa S., Hori M., Yamasaki Y., Matsuhisa M. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J. Biol. Chem. 2005, 280:847-851.
26. Nizielski S.E., Arizmendi C., Shteyngarts A.R., Farrell C.J., Friedman J.E. Involvement of transcription factor C/EBP-beta in stimulation of PEPCK gene expression during exercise. Am. J. Physiol. 1996, 270:R1005-R1012.
27. Oyadomari S., Harding H.P., Zhang Y., Oyadomari M., Ron D. Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice. Cell Metab. 2008, 7:520-532.
28. Ozawa K., Miyazaki M., Matsuhisa M., Takano K., Nakatani Y., Hatazaki M., Tamatani T., Yamagata K., Miyagawa J., Kitao Y., Hori O., Yamasaki Y., Ogawa S. The endoplasmic reticulum chaperone improves insulin resistance in type 2 diabetes. Diabetes 2005, 54:657-663.
29. Ozcan U., Cao Q., Yilmaz E., Lee A.H., Iwakoshi N.N., Ozdelen E., Tuncman G., Gorgun C., Glimcher L.H., Hotamisligil G.S. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004, 306:457-461.
30. Ozcan U., Yilmaz E., Ozcan L., Furuhashi M., Vaillancourt E., Smith R.O., Gorgun C.Z., Hotamisligil G.S. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006, 313:1137-1140.
31. Park E.A., Gurney A.L., Nizielski S.E., Hakimi P., Cao Z., Moorman A., Hanson R.W. Relative roles of CCAAT/enhancer-binding protein beta and cAMP regulatory element-binding protein in controlling transcription of the gene for phosphoenolpyruvate carboxykinase (GTP). J. Biol. Chem. 1993, 268:613-619.
32. Qadri I., Hu L.J., Iwahashi M., Al-Zuabi S., Quattrochi L.C., Simon F.R. Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue specific hormonal expression of human multidrug resistance-associated protein 2 (abcc2). Toxicol. Appl. Pharmacol. 2009, 234:281-292.
33. Rahman S.M., Qadri I., Janssen R.C., Friedman J.E. Fenofibrate and PBA prevent fatty acid-induced loss of adiponectin receptor and pAMPK in human hepatoma cells and in hepatitis C virus-induced steatosis. J. Lipid Res. 2009, 50:2193-2202.
34. Rahman S.M., Schroeder-Gloeckler J.M., Janssen R.C., Jiang H., Qadri I., Maclean K.N., Friedman J.E. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis. Hepatology 2007, 45:1108-1117.
35. Ramji D.P., Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 2002, 365:561-575.
36. Routes J.M., Colton L.A., Ryan S., Klemm D.J. CREB (cAMP response element binding protein) and C/EBPalpha (CCAAT/enhancer binding protein) are required for the superstimulation of phosphoenolpyruvate carboxykinase gene transcription by adenoviral E1a and cAMP. Biochem. J. 2000, 352(Pt 2):335-342.
37. Sag D., Carling D., Stout R.D., Suttles J. Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 2008, 181:8633-8641.
38. Schroeder-Gloeckler J.M., Rahman S.M., Janssen R.C., Qiao L., Shao J., Roper M., Fischer S.J., Lowe E., Orlicky D.J., McManaman J.L., Palmer C., Gitomer W.L., Huang W., O' Doherty R.M., Becker T.C., Klemm D.J., Jensen D.R., Pulawa L.K., Eckel R.H., Friedman J.E. CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice. J. Biol. Chem. 2007, 282:15717-15729.
39. Screaton R.A., Conkright M.D., Katoh Y., Best J.L., Canettieri G., Jeffries S., Guzman E., Niessen S., Yates J.R., Takemori H., Okamoto M., Montminy M. The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 2004, 119:61-74.
40. Shao J., Qiao L., Janssen R.C., Pagliassotti M., Friedman J.E. Chronic hyperglycemia enhances PEPCK gene expression and hepatocellular glucose production via elevated liver activating protein/liver inhibitory protein ratio. Diabetes 2005, 54:976-984.
41. Shaw R.J., Lamia K.A., Vasquez D., Koo S.H., Bardeesy N., Depinho R.A., Montminy M., Cantley L.C. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005, 310:1642-1646.
42. Verma G., Datta M. IL-1beta induces ER stress in a JNK dependent manner that determines cell death in human pancreatic epithelial MIA PaCa-2 cells. Apoptosis 2010, 15:864-876.
43. Wang D., Wei Y., Pagliassotti M.J. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 2006, 147:943-951.
44. Wang L., Shao J., Muhlenkamp P., Liu S., Klepcyk P., Ren J., Friedman J.E. Increased insulin receptor substrate-1 and enhanced skeletal muscle insulin sensitivity in mice lacking CCAAT/enhancer-binding protein beta. J. Biol. Chem. 2000, 275:14173-14181.
45. Wang X.Z., Harding H.P., Zhang Y., Jolicoeur E.M., Kuroda M., Ron D. Cloning of mammalian Ire1 reveals diversity in the ER stress responses. EMBO J. 1998, 17:5708-5717.
46. Wang Y., Vera L., Fischer W.H., Montminy M. The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis. Nature 2009, 21:21.
47. Yemelyanov A., Czwornog J., Chebotaev D., Karseladze A., Kulevitch E., Yang X., Budunova I. Tumor suppressor activity of glucocorticoid receptor in the prostate. Oncogene 2007, 26:1885-1896.